Authors:
KEHNE JH
KANE JM
CHANEY SF
HURST G
MCCLOSKEY TC
PETTY MA
SENYAH Y
WOLF HH
ZOBRIST R
WHITE HS
Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF MDL-27,192 AS A POTENTIAL BROAD-SPECTRUM ANTICONVULSANT AGENT WITH NEUROPROTECTIVE PROPERTIES, Epilepsy research, 27(1), 1997, pp. 41-54
Authors:
KEHNE JH
BARON BM
CARR AA
CHANEY SF
ELANDS J
FELDMAN DJ
FRANK RA
VANGIERSBERGEN PLM
MCCLOSKEY TC
JOHNSON MP
MCCARTY DR
POIROT M
SENYAH Y
SIEGEL BW
WIDMAIER C
Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF THE POTENTIAL OF THE PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100,907 AS A POTENT 5-HT2A ANTAGONIST WITH A FAVORABLE CNS SAFETY PROFILE, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 968-981
Authors:
THOMAS CE
BERNARDELLI P
BOWEN SM
CHANEY SF
FRIEDRICH D
JANOWICK DA
JONES BK
KEELEY FJ
KEHNE JH
KETTELER B
OHLWEILER DF
PAQUETTE LA
ROBKE DJ
FEVIG TL
Citation: Ce. Thomas et al., CYCLIC NITRONE FREE-RADICAL TRAPS - ISOLATION, IDENTIFICATION, AND SYNTHESIS OF 3,3-DIMETHYL-3,4-DIHYDROISOQUINOLIN-4-OL N-OXIDE, A METABOLITE WITH REDUCED SIDE-EFFECTS, Journal of medicinal chemistry, 39(25), 1996, pp. 4997-5004